Privia Health Group

Privia Health Group stock hits 52-week low at 19.52 USD

Why Privia Health Group (PRVA) Is Getting Attention Now

Activists recently filed disclosures with the SEC that included Privia Health Group (PRVA), putting fresh attention on the physician-enablement specialist and how its shares trade around the latest ownership updates. At around US$19.85 per share, Privia Health Group has been under pressure, with the share price falling 6.4% over the past month and 16.1% over the last quarter. The 1-year total shareholder return is down 11.3%, pointing to fading momentum that may reflect investors reassessing...

Privia Health Group (PRVA) Stock Looks Rich Against Current Earnings

Privia Health Group shares most recently closed at US$19.85, and the weaker run in the stock raises a straightforward question for investors who care about valuation. Is the current price fully supported by the earnings profile of Privia Health Group, or has sentiment moved further than the underlying profit story? Over the past 5 years the share price has fallen 23.1%, which puts the focus firmly on whether the current earnings justify staying invested or stepping in now. The business model...

1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore

Detailed price information for Capital One Financial (COF-N) from The Globe and Mail including charting and trades.

Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest

Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ:PRVA) and its peers.

Privia Health (PRVA): Buy, Sell, or Hold Post Q2 Earnings?

Privia Health has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $21.63. The stock also fell short of the S&P 500’s 11.3% gain during that period.